Oscar Health reaffirms FY2025 guidance at Raymond James conference

Oscar Health, Inc.

Company participates in 2025 Raymond James Institutional Investors Conference on March 3.
Reaffirms full year 2025 guidance originally provided on Feb 4, 2025 in Q4 2024 earnings release.
No new financial information or changes disclosed in this filing.

item 7.01

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-043364

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.